As announced in March, Soolantra has been approved for sale in Europe. The official prescribing information for Soolantra in the EEA has been published. The names are all pretty obvious – making it clear why Galderma would invent a new name for their product. The only exception is that Soolantra will be known as Vastreka […]
(Click image for a larger view). (Left) One hour following application of Mirvaso with initial blanching and improvement of baseline erythema. (Right) Twelve hours following application of Mirvaso with significant increase in baseline erythema. A recently published short article in Dermatology Online Journal is proposing the use of the term Dermatitis Medicamentosa to describe one […]
A poster session at the just completed 2015 AAD Meeting in San Francisco has published some results that show a special formulation of Kanuka Honey is able to benefit rosacea sufferers. The information around this announcement tells us that a `large clinical trial has proved that Honevo, a medical grade kanuka honey formulation, developed by […]
A session at the recent 2015 AAD meeting in San Francisco offered the following summary of the status of the development of the Finacea Foam product. Probably the most interesting new bit of information is that Finacea Foam is expected to approved in August this year. What’s New in Rosacea Therapy? Zoe Diana Draelos, MD […]
Galderma has announced that Soolantra has been approve across the 28 European Member States. Soolantra was approved in the US by the FDA in December 2014, so the European approvals took just an additional 3 months. Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA (ivermectin) Cream 10mg/g for Rosacea Patients MARCH […]
